Key result
Current antipsychotics linked to ~250% higher VTE risk, while antidepressants show no association.
Why the study?
Does exposure to antipsychotic or antidepressant drugs increase the risk of venous thromboembolism?
Population
1,354 patients, comprising 677 cases hospitalized with deep vein thrombosis and/or pulmonary embolism with…
Comparison
Current use of neuroleptic or antidepressant… vs Non-use of neuroleptic or antidepressant drugs.
Design
Case-control
Authors
Loading...
May heighten VTE vigilance with antipsychotics; leaves open causality and needs prospective confirmation.
Case-Control (n=1,354)
Does exposure to antipsychotic or antidepressant drugs increase the risk of venous thromboembolism?
Odds Ratio: 3.5 (95% CI 2–6.2)
Exposure to antipsychotic drugs, but not antidepressants, is associated with a significantly increased risk of venous thromboembolism, suggesting clinicians should consider it a potential risk factor.
Lacut et al. (2007) conducted a case-control in Venous thromboembolism (n=1,354). Antipsychotic and antidepressant drugs vs. Non-use was evaluated on Venous thromboembolism (OR 3.5, 95% CI 2.0-6.2). Current exposure to antipsychotic agents was associated with an increased risk of venous thromboembolism (OR 3.5; 95% CI 2.0-6.2), whereas antidepressant exposure showed no association.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: